Fetal exposure to (±)-methylenedioxymethamphetamine in utero enhances the development and metabolism of serotonergic neurons in three-dimensional reaggregate tissue culture

Developmental Brain Research

Volumn 137, Issue 1, 2002, Pages 67-73

  Won, Lisa ^a   Bubula, Nancy ^a   Heller, Alfred ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Ecstasy; MDMA; Mesostriatal; Prenatal drug; Serotonin; Tissue culture

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; DIHYDROXYPHENYLACETIC ACID; NEUROTRANSMITTER; SEROTONIN; DOPAMINE; SEROTONIN RECEPTOR AFFECTING AGENT;

ANIMAL TISSUE; ARTICLE; CELL AGGREGATION; CELL METABOLISM; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; FEMALE; GESTATIONAL AGE; MESENCEPHALON; MOUSE; NERVE CELL DIFFERENTIATION; NERVE PROJECTION; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROTONINERGIC NERVE CELL; STRIATE CORTEX; WEIGHT GAIN; ANIMAL; C57BL MOUSE; CELL COUNT; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; FETUS; LITTER SIZE; NERVE CELL; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

ANIMALS; CELL COUNT; CELLS, CULTURED; DOPAMINE; FEMALE; FETUS; LITTER SIZE; MICE; MICE, INBRED C57BL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURONS; PREGNANCY; PREGNANCY COMPLICATIONS; SEROTONIN; SEROTONIN AGENTS; WEIGHT GAIN;

EID: 0037199327     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(02)00411-X     Document Type: Article

References (40)

1. MDMA (ecstasy) effects on cultured serotonergic neurons: Evidence for Ca2(+)-dependent toxicity linked to release
2. MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons
3. Tissue distribution of methamphetamine and amphetamine in premature infants
4. Dopaminergic neurons grown in three-dimensional reaggregate culture for periods of up to one year
5. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy
6. Sympathomimetic actions of methylenedioxymethamphetamine in rat and rabbit isolated cardiovascular tissues
7. Prenatal development of the biogenic amine systems of the mouse brain
8. Altered serotonin innervation patterns in the forebrain of monkeys treated with (±)3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery
9. Elevation of fetal dopamine following exposure to methamphetamine in utero
10. Gender-dependent enhanced adult neurotoxic response to methamphetamine following fetal exposure to the drug
11. Fetal exposure to methamphetamine in utero enhances methamphetamine induced release of striatal dopamine in the rat
12. Reaggregate cultures
13. Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro
14. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat
15. Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user
16. MDMA induced dopamine release in vivo: Role of endogenous serotonin
17. Manipulation of mobile phase parameters for the HPLC separation of endogenous monoamines in rat brain tissue
18. Neurotoxic effects of methamphetamine assessed in three-dimensional reaggregate tissue cultures
19. Survival of developing dopaminergic neurons in reaggregate tissue culture following treatment with methamphetamine
20. The biochemical and morphological development of differentiating dopamine neurons co-aggregated with their target cells of the corpus striatum in vitro
21. Ontogeny of the serotonergic system in the rat: Serotonin as a developmental signal
22. Roles for neurotransmitters in development: Possible interaction with drugs during the fetal and neonatal periods
23. Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity
24. (±)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: Clinical studies
25. Congenital anomalies after prenatal ecstasy exposure
26. Ecstasy (MDMA): A review of its possible persistent psychological effects
27. (±)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates
28. Dose-related effects of prenatal 5-methoxytryptamine (5-MT) on development of serotonin terminal density and behavior
29. Measurement of protein using bicinchoninic acid
30. Prenatal cocaine increases striatal serotonin innervation without altering the patch/matrix organization of intrinsic cell types
31. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats
32. Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats
33. Autoregulation of fetal serotonergic neuronal development: Role of high affinity serotonin receptors
34. Fetal exposure to methamphetamine in utero stimulates development of serotonergic neurons in three-dimensional reaggregate tissue culture
35. Methamphetamine concentrations in fetal and maternal brain following prenatal exposure
36. In utero exposure to nicotine increases neurotransmitter release from monoaminergic neurons in reaggregate tissue culture
37. Acute and persistent effects of methamphetamine on developing monoaminergic neurons in reaggregate tissue culture
38. Correlated light and electron microscopic study of dopaminergic neurons and their synaptic junctions with DARPP-32-containing cells in three-dimensional reaggregate tissue culture
39. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat